However, a numerical trend in more coronary thrombotic events (MI, urgent revascularization, and stent thrombosis) with placebo versus aspirin.
← all excerpts
Anticoagulation in Patients with Atrial Fibrillation and Coronary Artery Disease.
1
—
—
However, a numerical trend in more coronary thrombotic events (MI, urgent revascularization, and stent thrombosis) with placebo versus aspirin.